+ Effects of Quality Improvement Strategies on Diabetes Care Presented by: Cali Trepp, Caitlin Dowhie, and Rosa Sanchez.

Slides:



Advertisements
Similar presentations
Patient Safety and Quality of Care: Role of the Compliance Professional Harvey V. Fineberg, M.D., Ph.D. Sixth Annual National Congress on Health Care Compliance.
Advertisements

Organization of Diabetes Care Chapter 6 Maureen Clement, Betty Harvey, Doreen M Rabi, Robert S Roscoe, Diana Sherifali Canadian Diabetes Association 2013.
Disease State Management The Pharmacist’s Role
99.98% of the time patients are on their own “The diabetes self-management regimen is one of the most challenging of any for chronic illness.” 0.02% of.
Mortality benefit from reduction in sodium consumption 1 Hypertension affects one-third of the US population, of which less than half have their blood.
Innovative Pharmacy Services Jann B. Skelton, RPh, MBA Vice President of Operations MEDICA.
National Institute for Health and Clinical Excellence.
Temporal Trends in the Prevalence of Diabetic Kidney Disease in the United States Ian H. de Boer, MD, MS, Tessa C. Rue, MS, Yoshio N. Hall, MD, Patrick.
Overview of the CVD Risk Reduction Demonstration Project Kelly Acton, MD, MPH, FACP IHS Division of Diabetes Treatment & Prevention.
CVD Risk Factor Reduction Kelly Moore, MD, FAAP IHS Division of Diabetes Treatment & Prevention.
Management of Hypertension according to JNC 7 BY SANDAR KYI, MD.
Author Names, Degree, Affiliation Author Name, Degrees, Affiliation – Helvetica Indiana University School of Medicine, Indianapolis Indiana Developing.
Health Disparities in Cardiovascular Disease Paula A. Johnson, MD, MPH Chief, Division of Women’s Health; Executive Director, Connors Center for Women’s.
Source: Site Name and Year IHS Diabetes Audit Diabetes Health Status Report ______Site Name_________ Health Outcomes and Care Given to Patients with Diabetes.
Heart Health Project University of Pennsylvania School of Medicine American Heart Association Pennsylvania State University Funded by the Robert Wood Johnson.
Introduction Approximately 1 in 3 of adults, have cardiovascular disease vascular/metabolic risk factors such as hypertension, dyslipidemia, and diabetes;
Coordinated Chronic Disease Prevention and Health Promotion State Planning Process Friedell Committee Fall Conference November 12, 2012 KDPH Chronic Disease.
AN ASSESSMENT OF THE PRIMARY PREVENTION CONTROL PROGRAM OF PHC PREVENTIVE CARDIOLOGY CLINIC AMONG PATIENTS AT RISK FOR CVD: A Retrospective Cohort Study.
Figure 1. Uninsured Rates Are Highest Among Hispanics and African Americans, 2005 Percent of adults ages 19–64 Note: Because of rounding, totals above.
Quality improvement in non glycaemic targets in diabetic patients at Central Australian Aboriginal Congress John Boffa Public Health Medical Officer.
Effect of Hypertension and Dyslipidemia on glycemic control among Type 2 Diabetes patients in Thailand Dr. Mya Thandar Dr.PH. Batch 5 1.
IMPROVING DIABETES CARE FOR ADULTS: A Population-Based Approach Patrick J. O’Connor, MD, MPH Senior Clinical Investigator HealthPartners Research Foundation.
Basma Y. Kentab MSc.. 1. Define ambulatory care 2. Describe the value of ambulatory care practices 3. Explore pharmacy services in some ambulatory care.
The 2004 Healthcare Conference April 2004, Scarman House, University of Warwick David Mirkin & Joanne Alder.
Looking for a new chronic care delivery model January 24th 2012 Irina Odnoletkova, Project Manager Innovations.
VA/DoD 2006 Clinical Practice Guideline For Screening and Management of Overweight and Obesity Guideline Summary: Key Elements.
Use of Computerized Clinical Decision Support System and Registry Functions to Track and Improve Clinical Outcomes Pamela Ferrari RN Director of Performance.
Can pharmacists improve outcomes in hypertensive patients? Sookaneknun P (1), Richards RME (2), Sanguansermsri J(1), Teerasut C (3) : (1)Faculty of Pharmacy,
Diabetes Mellitus Primary Care QI Project – Year III Mary Altier, RN, Bonnie Fiala-Bayser, Ph.D., William Cannon, MD, David Goldberg, MD, Jan Jandrisits,
ABSTRACT Diabetes is a public health issue of growing magnitude. It currently ranks among the top ten leading causes of death in the United States. To.
Effect of Hypertension and Dyslipidemia on glycemic control among Type 2 Diabetes patients in Thailand Dr. Mya Thandar DrPH Batch 5 1.
AIM Statement The use of reminders to eligible patients in the Resident Clinic to have a mammogram will improve rates of screening. Over a 6 month period,
The Role of Disease Management in Medical Research and Quality David Atkins, MD, MPH Agency for Healthcare Research and Quality Disease Management Colloquium,
3 rd Annual Right Care Summit October 1 st, 2010 Stephen M. Shortell Ph.D., M.P.H. Dean, University of California, Berkeley, School of Public Health.
Teresa Hudson, PharmD Center for Mental Healthcare and Outcomes Research South Central Mental Illness Research Education and Clinical Center.
Diabetes Health intelligence Jon Walker Advanced public health analyst Surrey County Council
Diabetes Health intelligence Jon Walker Advanced public health analyst Surrey County Council
Journal Club Alcohol, Other Drugs, and Health: Current Evidence November-December 2012.
Disease Management in Managed Care  Next generation of “Managed Care” –Disease Management for populations –Advanced Care Management for Individuals 
Complex Medical Patients Wayne Katon, MD.  Definition: Illnesses with high prevalence, high comorbidity and bidirectional adverse interactions Examples:
Do Group Visits Improve Care? Results of a Diabetes Group Visit Model in a Family Medicine Residency Authors: Josephine Agbowo MD, Grace Chen Yu, MD Location:
PRACTICE TRANSFORMATION NETWORK 2/24/ Transforming Clinical Practice Initiative (TCPI) Practice Transformation Network (PTN)  $18.6 million –
The MICRO-HOPE. Microalbuminuria, Cardiovascular and Renal Outcomes in the Heart Outcomes Prevention Evaluation Reference Heart Outcomes Prevention Evaluation.
High Value Quality Improvement Presentation 6 of 6.
Improving risk factor management for patients with poorly controlled type 2 diabetes: a systematic review of non-pharmaceutical interventions in primary.
Obesity and Hypertension: Vulnerable Population Care Plan Nicole Chan GNRS 587 July 16, 2015.
Clinical Quality Improvement: Achieving BP Control
Management of Hypertension according to JNC 7
Our unique strategy Seamless integration = Total health engagement
Hypertension November 2016
2017 Provider Incentive Program: Targets
Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults Risks and Assessment NHLBI Obesity Education.
Chelsea Stellmach, MS with Alison DiValerio, MS, RN
برنامه راهبردی پیشگیری و کنترل بیماری های قلبی عروقی
Hemoglobin A1c Targets for Glycemic Controls
Resistant Hypertension
National Association of Medicaid Director’s Fall Conference
Developing and Using a Referral Network
Case Study. Managing Medication and Adherence in SIHD: Partnering With the Patient to Improve Care.
Section VII: Summary New focus on treating hypertension beyond the numbers Content Points: In view of current clinical understanding of the link between.
Pharmaceutical care planning 2 Ola Ali Nassr
The Rising Crisis of Prediabetes Diagnosis and Management of the Patient With Prediabetes.
Reasons patients were excluded from the switch from atorvastatin to simvastatin J. A. Usher-Smith, et al. Int J Clin Pract 2007; 61:15–23.
IMPACT OF PHARMACIST DELIVERED CARE IN THE COMMUNITY PHARMACY SETTING
Hypertension November 2016
Epidemiological Terms
Change in (A) systolic blood pressure and (B) diastolic blood pressure over 5 years in response to 12-week intensive lifestyle intervention in a real-world.
Number of antihypertensive agents prescribed for known nephropaths in phases I and II (▪), with blood pressure recordings falling outside guidelines, compared.
HR for mortality in ischemic heart disease.
Average change in blood pressure (BP) from recruitment to 6-month postrecruitment in intervention and control patients >50 years included due to having.
Presentation transcript:

+ Effects of Quality Improvement Strategies on Diabetes Care Presented by: Cali Trepp, Caitlin Dowhie, and Rosa Sanchez

+ Current Care of Diabetes What percentage of Diabetic patients are hypertensive? It is estimated that more than one-third of patients are hypertensive (Shojania et al., 2004). What percentage of Diabetic patients have elevated LDL-cholesterol levels? More than one-half of patients have elevated LDL-cholesterol levels (Shojania et al., 2004). How many Diabetic patients receive recommended Hba1c measurements? Only 28% of diabetics receive the recommended HbA 1c measurements (Shojania et al., 2004). Thus, many patients are not receiving sufficient care despite constant treatment advances. Based on these numbers, what does that tell us?

+ Quality Gaps in Care Prevention screening Treatment processes Improvements in these areas decrease morbidity and mortality (Shojania et al., 2004).

+ Our Study Analyzes the effects of quality improvement strategies on diabetes care to address quality gaps. Literature review

+ Scope Focused on adults with type 2 Diabetes Did not focus on children because of a higher prevalence of type 1 Diabetes Did not include gestational Diabetes

+ Inclusion -What research was included? evaluate an intervention meeting the authors' definition for quality improvement use an experimental or quasi-experimental design report at least one measure of disease control, provider adherence, or patient compliance

+ Interventions Utilized Provider reminders Facilitated relay of clinical data to provider Audit and feedback Provider education Patient education Promotion of self-management Patient reminders Organizational change Financial, regulatory, or legislative incentives

+ Outcomes Researchers targeted three broad categories of study outcomes when selecting literature: measures of disease control measures of provider adherence to recommended care patient adherence to prescribed medications and self-care recommendations

+ How can we measure these outcomes? Reduction of HbA1 c, systolic blood pressure, and diastolic blood pressure Changes in adherence were reported using a percentage of patients in each group who received care before and after intervention

+

+

+

+

+ Let’s see what you remember!

+ Why is the use of QI strategies important in Diabetes care? Decrease mortality and morbidity Improve treatment and screening processes

+ What were two QI strategies this study utilized? Provider reminders, facilitated relay of clinical data to providers, audit and feedback, provider education, patient education, promotion of self-management, patient reminders, organizational change, and financial, regulatory, or legislative incentives

+ Name one outcome the study analyzed? (What changes were they observing? measures of disease control measures of provider adherence to recommended care patient adherence to prescribed medications and self-care recommendations